Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.


We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.



We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.


An online stream from deCODE’s 25th anniversary conference will be available, during the days of May 18th and 19th, here below or on Youtube by the following links:

Youtube stream – Day 1

Youtube stream – Day 2

Please note that if the player does not appear below, you might have to consent to the use of cookies by clicking on the banner in the lower right corner of the window.


New study on inheritance and fetal growth

New study on inheritance and fetal growth

Scientists from deCODE genetics have mapped 243 sequence variants affecting fetal growth, separating maternal genome and fetal genome. It sheds light on the relationships between hypertension, diabetes and fetal growth

New biomarker for osteoarthritis

New biomarker for osteoarthritis

Scientists at deCODE genetics have found a new biomarker for osteoarthritis, that outperforms previously reported biomarkers and is an independent predictor of disease.

Award by the American Society of Human Genetics

At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.